微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 95.8% | -0.38% | 0.18% | 3/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 95.63% | -0.49% | 0.21% | 3/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 95.43% | -1.59% | -0.74% | 4/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 96.14% | 0.16% | -0.03% | 4/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 96.17% | 0.42% | 0.07% | 2/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 96.11% | 0.29% | -0.89% | 2/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 96.97% | 1.66% | 1.03% | 2/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 95.99% | -2.98% | 0.23% | 3/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 95.77% | -3.66% | -0.06% | 2/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 95.83% | -2.91% | 0.45% | 2/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 95.39% | -4.03% | -3.58% | 2/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 98.94% | 39.01% | -0.47% | 2/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 99.41% | 2% | 0.71% | 1/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 98.7% | 30.71% | -0.7% | 1/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 99.4% | 2% | 39.66% | 1/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 71.17% | 24.74% | -5.75% | 36/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-06-30 | 75.51% | 2% | 32.35% | 24/160 | 54.32% | 泽璟制药 | 99.96% | 行业排名> |
| 2019-12-31 | 57.06% | 2% | 2% | 67/160 | -1204.25% | 微芯生物 | 95.14% | 行业排名> |